These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24952669)

  • 41. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
    Hartmann JU; Bräuer-Hartmann D; Kardosova M; Wurm AA; Wilke F; Schödel C; Gerloff D; Katzerke C; Krakowsky R; Namasu CY; Bill M; Schwind S; Müller-Tidow C; Niederwieser D; Alberich-Jorda M; Behre G
    Cell Death Dis; 2018 Jul; 9(8):814. PubMed ID: 30050105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
    Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
    J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.
    Yin L; Wu Z; Avigan D; Rosenblatt J; Stone R; Kharbanda S; Kufe D
    Blood; 2011 May; 117(18):4863-70. PubMed ID: 21422470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia.
    Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y
    Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.
    Wojtuszkiewicz A; Schuurhuis GJ; Kessler FL; Piersma SR; Knol JC; Pham TV; Jansen G; Musters RJ; van Meerloo J; Assaraf YG; Kaspers GJ; Zweegman S; Cloos J; Jimenez CR
    Mol Cell Proteomics; 2016 Apr; 15(4):1281-98. PubMed ID: 26801919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy.
    Drolle H; Wagner M; Vasold J; Kütt A; Deniffel C; Sotlar K; Sironi S; Herold T; Rieger C; Fiegl M
    Leuk Res; 2015 Jul; 39(7):779-85. PubMed ID: 25982178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
    Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
    Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.
    Rahaman MH; Yu Y; Zhong L; Adams J; Lam F; Li P; Noll B; Milne R; Peng J; Wang S
    Invest New Drugs; 2019 Aug; 37(4):625-635. PubMed ID: 30194564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.
    Callens C; Coulon S; Naudin J; Radford-Weiss I; Boissel N; Raffoux E; Wang PH; Agarwal S; Tamouza H; Paubelle E; Asnafi V; Ribeil JA; Dessen P; Canioni D; Chandesris O; Rubio MT; Beaumont C; Benhamou M; Dombret H; Macintyre E; Monteiro RC; Moura IC; Hermine O
    J Exp Med; 2010 Apr; 207(4):731-50. PubMed ID: 20368581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL.
    Hundsdoerfer P; Dietrich I; Schmelz K; Eckert C; Henze G
    Pediatr Blood Cancer; 2010 Aug; 55(2):260-6. PubMed ID: 20582956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
    Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
    Tamm I; Kornblau SM; Segall H; Krajewski S; Welsh K; Kitada S; Scudiero DA; Tudor G; Qui YH; Monks A; Andreeff M; Reed JC
    Clin Cancer Res; 2000 May; 6(5):1796-803. PubMed ID: 10815900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.
    Gadhoum Z; Delaunay J; Maquarre E; Durand L; Lancereaux V; Qi J; Robert-Lezenes J; Chomienne C; Smadja-Joffe F
    Leuk Lymphoma; 2004 Aug; 45(8):1501-10. PubMed ID: 15370200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
    Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
    Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.